United States
Germany
Japan
United Kingdom
China
MAP2K1 mouse monoclonal antibody,clone OTI4E1
| Applications | IF, IHC, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
Antibodies
MAP2K1 (MEK1) mouse monoclonal antibody, clone OTI3H3 (formerly 3H3)
| Applications | IF, IHC, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
CNY 3,990.00
2周
CNY 3,990.00
2周
MAP2K1 (MEK1) mouse monoclonal antibody, clone OTI2B2 (formerly 2B2)
| Applications | IF, IHC, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
MAP2K1 (MEK1) mouse monoclonal antibody, clone OTI2D4 (formerly 2D4)
| Applications | IF, IHC, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
MAP2K1 (MEK1) mouse monoclonal antibody, clone OTI7E2 (formerly 7E2)
| Applications | IF, IHC, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
MAP2K1 (MEK1) mouse monoclonal antibody, clone OTI4F1 (formerly 4F1)
| Applications | IF, IHC, WB |
| Reactivities | Human, Dog, Rat, Mouse |
MAP2K1 (MEK1) mouse monoclonal antibody, clone OTI3H5 (formerly 3H5)
| Applications | IF, IHC, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
MAP2K1 (MEK1) mouse monoclonal antibody, clone OTI4B1 (formerly 4B1)
| Applications | IF, IHC, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
活动过滤器
优化搜索结果
Category
Reactivities
Antibody Hosts
Knockout (KO) Validation
Conjugates
Isotypes
Clonalities
Brands
Pathways
- Acute myeloid leukemia (182)
- B cell receptor signaling pathway (182)
- Bladder cancer (182)
- Chemokine signaling pathway (182)
- Chronic myeloid leukemia (182)
- Colorectal cancer (182)
- Dorso-ventral axis formation (182)
- Endometrial cancer (182)
- ErbB signaling pathway (182)
- Fc epsilon RI signaling pathway (182)
- Fc gamma R-mediated phagocytosis (182)
- Focal adhesion (182)
- Gap junction (182)
- Glioma (182)
- GnRH signaling pathway (182)
- Insulin signaling pathway (182)
- Long-term depression (182)
- Long-term potentiation (182)
- MAPK signaling pathway (182)
- Melanogenesis (182)
- Melanoma (182)
- Natural killer cell mediated cytotoxicity (182)
- Neurotrophin signaling pathway (182)
- Non-small cell lung cancer (182)
- Oocyte meiosis (182)
- Pancreatic cancer (182)
- Pathways in cancer (182)
- Prion diseases (182)
- Progesterone-mediated oocyte maturation (182)
- Prostate cancer (182)
- Regulation of actin cytoskeleton (182)
- Renal cell carcinoma (182)
- T cell receptor signaling pathway (182)
- Thyroid cancer (182)
- Toll-like receptor signaling pathway (182)
- VEGF signaling pathway (182)
- Vascular smooth muscle contraction (182)
